Wegovy, Zepbound, and Foundayo Coverage for Medicare Patients with the Bridge Program
Claim your complimentary gift of my exclusive mini weight care guide today!
Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)
What if Medicare finally made GLP-1 medications for weight management more affordable — could this be the moment that changes access for millions of people?
Today, we're talking about something that's been years in the making in the world of obesity care: the expanded coverage of anti-obesity medications for patients on Medicare. Starting July 1st, eligible Medicare beneficiaries have a real opportunity to access GLP-1 receptor agonist medications at a much more affordable monthly cost through a new federal program — and for many patients, this could mark a major shift in access to treatment that's historically been limited or completely out of reach under Medicare's coverage rules.
This change didn't happen overnight. It comes after years of advocacy, policy discussions, and ongoing efforts to get obesity recognized as a chronic medical condition that deserves treatment just like any other disease. In this episode, we break down where this program came from, how it connects to the bigger picture of obesity care, who it applies to, and everything you need to know about eligibility, covered medications, and how the process actually plays out in real life.
Topics discussed:
How the Bridge Program Could Expand Access to Obesity Medications
For the First Time, Medicare Is Opening the Door to Obesity Medications
The BMI and Health Condition Criteria
Why the Reason for Your Prescription Matters Just as Much
The Details That Make a Real Difference — Prior BMI and Lifestyle Support
The List of Weight Loss Medications Covered by the Bridge Program
Want the full breakdown? This episode covers all the details on eligibility, covered medications, and what this program could mean for you or someone you love navigating Medicare and obesity treatment. Find it wherever you get your podcasts — and if it helps, share it with someone who might need to hear it too.
Resources mentioned in this episode:
GLP-1 Prescribers Guide — CMS
Medicare GLP-1 Bridge Program Details — CMS
Connect with me:
Instagram: doctorfrancavilla
Facebook: Help Your Patients Lose Weight with Dr. Francavilla
Website: Dr. Francavilla Show
Youtube: The Doctor Francavilla Show
GLP Strong: glpstrong.com
Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)
What if Medicare finally made GLP-1 medications for weight management more affordable — could this be the moment that changes access for millions of people?
Today, we're talking about something that's been years in the making in the world of obesity care: the expanded coverage of anti-obesity medications for patients on Medicare. Starting July 1st, eligible Medicare beneficiaries have a real opportunity to access GLP-1 receptor agonist medications at a much more affordable monthly cost through a new federal program — and for many patients, this could mark a major shift in access to treatment that's historically been limited or completely out of reach under Medicare's coverage rules.
This change didn't happen overnight. It comes after years of advocacy, policy discussions, and ongoing efforts to get obesity recognized as a chronic medical condition that deserves treatment just like any other disease. In this episode, we break down where this program came from, how it connects to the bigger picture of obesity care, who it applies to, and everything you need to know about eligibility, covered medications, and how the process actually plays out in real life.
Topics discussed:
How the Bridge Program Could Expand Access to Obesity Medications
For the First Time, Medicare Is Opening the Door to Obesity Medications
The BMI and Health Condition Criteria
Why the Reason for Your Prescription Matters Just as Much
The Details That Make a Real Difference — Prior BMI and Lifestyle Support
The List of Weight Loss Medications Covered by the Bridge Program
Want the full breakdown? This episode covers all the details on eligibility, covered medications, and what this program could mean for you or someone you love navigating Medicare and obesity treatment. Find it wherever you get your podcasts — and if it helps, share it with someone who might need to hear it too.
Resources mentioned in this episode:
GLP-1 Prescribers Guide — CMS
Medicare GLP-1 Bridge Program Details — CMS
Connect with me:
Instagram: doctorfrancavilla
Facebook: Help Your Patients Lose Weight with Dr. Francavilla
Website: Dr. Francavilla Show
Youtube: The Doctor Francavilla Show
GLP Strong: glpstrong.com
Loading content...
Read the full transcript
Matterfact has every podcast on Apple Podcasts and Spotify: 700K+ channels, 120M+ episodes.
The candid version is on a podcast,
not the earnings call.
Matterfact turns the conversations your coverage is already having into a searchable, citable record — across every episode, not just this one.